Anupam Rasayan corrects Bliss Pharma acquisition share-count disclosure

Anupam Rasayan clarified that its PAC acquired 5,09,84,595 equity shares, representing 47.95%, of Bliss GVS Pharma on 28 September 2026 under the share purchase agreement. It also corrected the number of Bliss shares credited to Anupam Rasayan’s demat account on 24 August 2026 to 1,669 from 1,699; the Acquirer’s total disclosed holding acquired is 22,51,669 shares.

An acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.

• Consideration and how it is funded
• Revenue and profit of the target
• Expected completion date
• we should be below 200, around 180 days or below is the management's focus and target here. (management committed by FY27)
• we expect that in the near-term we should be going towards 220, 200. (management committed by FY27)